330 related articles for article (PubMed ID: 19730006)
1. Albumin dialysis MARS: knowledge from 10 years of clinical investigation.
Mitzner SR; Stange J; Klammt S; Koball S; Hickstein H; Reisinger EC
ASAIO J; 2009; 55(5):498-502. PubMed ID: 19730006
[TBL] [Abstract][Full Text] [Related]
2. Albumin dialysis: an update.
Mitzner SR
Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):589-95. PubMed ID: 18089976
[TBL] [Abstract][Full Text] [Related]
3. Extracorporeal liver support-albumin dialysis with the Molecular Adsorbent Recirculating System (MARS).
Mitzner SR
Ann Hepatol; 2011 May; 10 Suppl 1():S21-8. PubMed ID: 21566251
[TBL] [Abstract][Full Text] [Related]
4. Indications and therapeutic possibilities of albumin dialysis (MARS).
Bañares Cañizares R; Catalina Rodríguez MV
Rev Esp Enferm Dig; 2003 Dec; 95(12):876-89. PubMed ID: 14972008
[TBL] [Abstract][Full Text] [Related]
5. Albumin dialysis in liver failure: comparison of molecular adsorbent recirculating system and single pass albumin dialysis--a retrospective analysis.
Kortgen A; Rauchfuss F; Götz M; Settmacher U; Bauer M; Sponholz C
Ther Apher Dial; 2009 Oct; 13(5):419-25. PubMed ID: 19788459
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure.
Mitzner SR; Stange J; Klammt S; Peszynski P; Schmidt R; Nöldge-Schomburg G
J Am Soc Nephrol; 2001 Feb; 12 Suppl 17():S75-82. PubMed ID: 11251037
[TBL] [Abstract][Full Text] [Related]
7. Emerging indications for albumin dialysis.
Sen S; Williams R; Jalan R
Am J Gastroenterol; 2005 Feb; 100(2):468-75. PubMed ID: 15667509
[TBL] [Abstract][Full Text] [Related]
8. [Efficiency of dialysis with albumin in the treatment of patients with advanced hepatic insufficiency: initial experience with the MARS system in Spain].
Avilés J; Macía M; Morales S; Pérez F; Moreno A; Navarro J; Navazo L; García J
Nefrologia; 2001; 21(4):376-85. PubMed ID: 11816514
[TBL] [Abstract][Full Text] [Related]
9. Improvement of impaired albumin binding capacity in acute-on-chronic liver failure by albumin dialysis.
Klammt S; Mitzner SR; Stange J; Loock J; Heemann U; Emmrich J; Reisinger EC; Schmidt R
Liver Transpl; 2008 Sep; 14(9):1333-9. PubMed ID: 18756471
[TBL] [Abstract][Full Text] [Related]
10. The use of the molecular adsorbent recirculating system (MARS) albumin dialysis for the treatment of liver failure: a nursing perpective.
McCready R
Dynamics; 2009; 20(3):18-22. PubMed ID: 19953756
[TBL] [Abstract][Full Text] [Related]
11. Technology insight: artificial extracorporeal liver support--how does Prometheus compare with MARS?
Krisper P; Stauber RE
Nat Clin Pract Nephrol; 2007 May; 3(5):267-76. PubMed ID: 17457360
[TBL] [Abstract][Full Text] [Related]
12. [A pilot study of using pure albumin as a dialysate in the treatment of liver failure].
Liu Q; Peng L; Du Y; Li M; Jia N; Zou HQ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Oct; 17(10):599-602. PubMed ID: 16259917
[TBL] [Abstract][Full Text] [Related]
13. Predictive criteria for the outcome of patients with acute liver failure treated with the albumin dialysis molecular adsorbent recirculating system.
Novelli G; Rossi M; Ferretti G; Pugliese F; Ruberto F; Lai Q; Novelli S; Piemonte V; Turchetti L; Morabito V; Annesini MC; Berloco PB
Ther Apher Dial; 2009 Oct; 13(5):404-12. PubMed ID: 19788457
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic effects of albumin dialysis in patients with liver failure: for better or for worse?
Laleman W
Ther Apher Dial; 2009 Oct; 13(5):384-92. PubMed ID: 19788454
[TBL] [Abstract][Full Text] [Related]
15. Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience.
Chiu A; Chan LM; Fan ST
Liver Int; 2006 Aug; 26(6):695-702. PubMed ID: 16842326
[TBL] [Abstract][Full Text] [Related]
16. Albumin regeneration in liver support-comparison of different methods.
Mitzner S; Klammt S; Stange J; Schmidt R
Ther Apher Dial; 2006 Apr; 10(2):108-17. PubMed ID: 16684211
[TBL] [Abstract][Full Text] [Related]
17. Albumin dialysis: current practice and future options.
Wauters J; Wilmer A
Liver Int; 2011 Sep; 31 Suppl 3():9-12. PubMed ID: 21824276
[TBL] [Abstract][Full Text] [Related]
18. Early molecular adsorbents recirculating system treatment of Amanita mushroom poisoning.
Kantola T; Kantola T; Koivusalo AM; Höckerstedt K; Isoniemi H
Ther Apher Dial; 2009 Oct; 13(5):399-403. PubMed ID: 19788456
[TBL] [Abstract][Full Text] [Related]
19. Binding of bilirubin and bromosulphthalein to albumin: implications for understanding the pathophysiology of liver failure and its management.
Steiner C; Sen S; Stange J; Williams R; Jalan R
Liver Transpl; 2004 Dec; 10(12):1531-8. PubMed ID: 15558653
[TBL] [Abstract][Full Text] [Related]
20. Hypoglycemia in nondiabetic patients undergoing albumin dialysis by molecular adsorbent recirculating system.
Khoo AL; Tham LS; Lim GK; Lee KH
Liver Transpl; 2003 Sep; 9(9):949-53. PubMed ID: 12942456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
